| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 73621 |
Mal-PEG2-Val-Cit-PAB-OH ADC抗体偶联药物 |
83 |
zyl |
2024-12-19 |
| 73622 |
N3-PEG4-DYKDDDD-Doxorubicin，ADC定制 |
100 |
wyh |
2024-12-19 |
| 73623 |
MA-vc-PAB-DM1 cas:1464051-44-2 |
64 |
zyl |
2024-12-19 |
| 73624 |
DBCO-PEG4-VC-PAB-DMAE-Duocarmycin SA |
85 |
zyl |
2024-12-19 |
| 73625 |
VC-PAB-DMAE-PNU159682 ADC抗体偶联药物 |
81 |
zyl |
2024-12-19 |
| 73626 |
MC-GGFG-DX8951 cas:1600418-29-8 |
74 |
zyl |
2024-12-19 |
| 73627 |
DOTA-NGR NGR肽偶联1,4,7,10-四氮杂环十二烷-N,N’,N”,N”’-四乙酸(DOTA) |
89 |
h |
2024-12-19 |
| 73628 |
N3-PEG4-vc-PAB-Doxorubicin 叠氮PEG修饰维生素C-阿霉素的介绍 |
183 |
zyl |
2024-12-19 |
| 73629 |
DOTA-Ahx-(d-Lys6-GnRH1)DOTA偶联的d-Lys6-GnRH肽 |
87 |
h |
2024-12-19 |
| 73630 |
DOTA-porphyrin 双功能螯合剂DOTA偶联5-(对-氨基-丙烯-氧苯基)-10,15,20-三-(对-羧基-甲基-烯-氧苯基)卟啉 |
115 |
h |
2024-12-19 |
| 73631 |
VC-SECO DUBA analogue，ADC定制 |
91 |
wyh |
2024-12-19 |
| 73632 |
DOTA-H-Lys(Boc)-OH-SWCNTs 赖氨酸胺手柄功能化的单壁碳纳米管偶联DOTA螯合剂 |
85 |
h |
2024-12-19 |
| 73633 |
[DOTA-A1]-ZHER2:S1 抗HER2 ZHER2:S1亲和体分子缀合DOTA |
110 |
h |
2024-12-19 |
| 73634 |
Vc-MMAD cas:1401963-17-4的结构式 |
71 |
zyl |
2024-12-19 |
| 73635 |
DOTA-E(c(RGDfK))大环DOTA偶联双环肽E[c(RGDfK)] |
95 |
h |
2024-12-19 |
| 73636 |
CL2A-SN38，cas:1279680-68-0，ADC定制 |
158 |
wyh |
2024-12-19 |
| 73637 |
DOTA-gluBBN DOTA缀合铃蟾肽类似物 |
72 |
h |
2024-12-19 |
| 73638 |
DOTA-GSG-KCCYSL DOTA缀合物ErbB-2靶向肽KCCYSL |
145 |
h |
2024-12-19 |
| 73639 |
MC-MMAF ， cas:863971-19-1，ADC定制 |
110 |
wyh |
2024-12-19 |
| 73640 |
TCO-PEG4-Fmoc-Gly-Gly-Gly-ADC连接子 |
134 |
zyl |
2024-12-19 |
| 73641 |
模拟肽4-[2-(3,4,5,6-四氢嘧啶-2-基氨基)乙氧基]苯甲酰基-2-[N-(3-氨基-新戊-1-氨基甲酰基)]-氨乙基磺酰基-氨基-β-丙氨酸(IAC)缀合DOTA |
80 |
h |
2024-12-19 |
| 73642 |
DOTA-chCE7 DOTA标记的糖基化单克隆抗L1-CAM抗体chCE7 |
96 |
h |
2024-12-19 |
| 73643 |
Vc-MMAE， cas:646502-53-6，ADC定制 |
126 |
wyh |
2024-12-19 |
| 73644 |
Azido-PEG4-MMAE |
111 |
zyl |
2024-12-19 |
| 73645 |
cas:2055024-59-2，Fmoc-PEG2-Val-Cit-PAB-OH |
112 |
zyl |
2024-12-19 |
| 73646 |
Azide-PEG6-Val-Cit-PAB-PEG6- Biotin，ADC定制 |
113 |
wyh |
2024-12-19 |
| 73647 |
Ga-DOTA-(Asp)n 大环DOTA共轭(Asp)n肽 |
69 |
h |
2024-12-19 |
| 73648 |
cas:1807530-16-0，2-hydroxyethyl disulfide mono-Tosylate- ADC linker |
84 |
zyl |
2024-12-19 |
| 73649 |
DOTA偶联受体特异性肽 |
114 |
h |
2024-12-19 |
| 73650 |
聚乙二醇化DOTA-AHA基GdIII螯合物 PEGylated DOTA-based gadolinium(III) |
92 |
h |
2024-12-19 |
| 73651 |
PAMAM树状大分子DOTA缀合物 PAMAM–DOTA |
97 |
h |
2024-12-19 |
| 73652 |
ALD-tetra-EG-Osu的介绍 |
116 |
zyl |
2024-12-19 |
| 73653 |
SSTR2靶向肽Tyr(3)-奥曲肽(tate) |
214 |
h |
2024-12-19 |
| 73654 |
DOTA-D-Phe(1)-Tyr(3)-Octreotide |
88 |
h |
2024-12-19 |
| 73655 |
cas:55750-63-5，Mal-heptanoic NHS ester |
107 |
zyl |
2024-12-19 |
| 73656 |
DOTA-Fab-PEG24-EGF DOTA-PEG修饰曲妥珠单抗Fab片段偶联表皮生长因子 |
94 |
h |
2024-12-19 |
| 73657 |
cas:663599-10-8，DMAC-SPP |
102 |
zyl |
2024-12-19 |
| 73658 |
多甲基化的1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)配体 |
140 |
h |
2024-12-19 |
| 73659 |
PEG-pGlu(DOTA)8-LA4 |
52 |
h |
2024-12-19 |
| 73660 |
cas:937025-17-7，2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
140 |
zyl |
2024-12-19 |
| 73661 |
DOTA-Hyd-TRP PET示踪剂 |
101 |
h |
2024-12-19 |
| 73662 |
Ga-DOTATOC Ga-DOTA-D-Phe-Tyr-奥曲肽 |
136 |
h |
2024-12-19 |
| 73663 |
cas:1226371-65-8，N-(2-(2,5-Dimethylphenoxy)ethyl)-4-formylbenzamide |
77 |
zyl |
2024-12-19 |
| 73664 |
DOTA-ALN DOTA-阿仑膦酸盐 |
83 |
h |
2024-12-19 |
| 73665 |
氨氯地平DOTA偶联物 DOTA-Amlodipine |
142 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询